Navigation Links
Stem Cell Markets - 2013 Report Examines the Use of Stem Cells in Developing New Therapies for Disease
Date:11/20/2013

DUBLIN, Ireland, November 20, 2013 /PRNewswire/ --

Research and Markets
( http://www.researchandmarkets.com/research/59bkth/stem_cell_markets) has announced the addition of the "Stem Cell Markets" report to their offering.

     (Logo: http://photos.prnewswire.com/prnh/20130307/600769)


A stem cell is an extraordinary type of cell that has the ability to self-renew for long periods of time and to differentiate into specialized cells under appropriate physiological or experimental conditions. Traditionally, stem cells have been classified as either embryonic, adult (tissue-specific or cord blood) stem cells.

Recent understanding of stem cell biology may provide new approaches for the treatment of a number of diseases as well as tissue/organ injuries, including cardiovascular disease, neurological disease, musculoskeletal disease, diabetes and hematopoietic disorders. Stem cell fate is determined by both intrinsic regulators and the extra-cellular environment (niche), and their expansion and differentiation ex vivo are generally controlled by growing them in a specific configuration (monolayer or three-dimensional culture). This process, which is vital to enable stem cells to be used for therapeutic purposes, is called differentiation. Differentiation is a process involving unspecialized cells progressing to become specialized cells with restricted developmental potential.

The purpose of this report is to describe the specific market segments of the medical research space using stem cells for research and development (R&D) purposes. This study reviews all of the generally accepted analytical methods that are currently in use today for preparing and using stem cells.

Companies Mentioned:

- Aastrom Biosciences, Inc
- Athersys, Inc
- BD Biosciences
- Bioheart, Inc
- Brainstorm Cell Therapeutics, Inc
- Cardio3 BioSciences
- CryoLife, Inc
- Epistem PLC
- ES Cell International Pvt, Ltd
- Forticell Bioscience, Inc
- OrCel®
- Gamida Cell
- Humacyte, Inc
- Intercytex Group plc
- Japan Tissue Engineering Co., Ltd
- LifebankUSA
- Life Technologies Corporation
- Lonza
- MedCell Bioscience, Ltd
- Medistem, Inc
- Neostem, Inc
- Orthovita, Inc
- Osiris Therapeutics, Inc
- Pervasis Therapeutics, Inc
- Regenocyte Therapeutic
- Stempeutics Research Private Limited
- Tengion, Inc
- TheraVitae
- VistaGen Therapeutics, Inc
- ZenBio, Inc


For more information visit http://www.researchandmarkets.com/research/59bkth/stem_cell_markets

About Research and Markets
Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Research and Markets
Laura Wood, Senior Manager.
press@researchandmarkets.com
U.S. Fax: +1-646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Biotechnology



'/>"/>
SOURCE Research and Markets
Copyright©2012 PR Newswire.
All rights reserved

Related biology technology :

1. MarketsandMarkets: Lung Cancer Drugs Market in G7 Countries Worth $13 Billion by 2020
2. Sequenom Announces Participation at the Lazard Capital Markets 8th Annual Healthcare Conference
3. Organovo to Present at Lazard Capital Markets 8th Annual Healthcare Conference
4. Pharmasset to Present at the Lazard Capital Markets Healthcare Conference
5. MarketsandMarkets: Global Prostate Cancer Therapeutics Market worth $6,457 Million by 2020
6. MarketsandMarkets: Leukemia Therapeutics Market Worth $11.3 Billion by 2020
7. Animal Biotechnology - Technologies, Markets and Companies
8. Gene Therapy - Technologies, Markets and Companies
9. Biomarkers - Technologies, Markets and Companies
10. MarketsandMarkets: Acute Lymphocytic Leukemia Therapeutics Market worth $3.88 Billion by 2020
11. MarketsandMarkets: Chronic Lymphocytic Leukemia Therapeutics Market Worth $2.2 Billion by 2020
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/8/2016)... SHELTON, Conn. , Feb. 8, 2016  NanoViricides, Inc. (NYSE ... that its CEO, Eugene Seymour , MD, MPH, will present ... 5:30PM at the Waldorf-Astoria Hotel in New York City ... presentation will be in the Windsor Room at 5:30PM EST. Registered ... New York City . --> ...
(Date:2/6/2016)... VA (PRWEB) , ... February 06, 2016 , ... The ... session, cost-free, for middle and high school teachers on Wednesday February 10, 2016. ... held at the Smithsonian-Mason School of Conservation, located at 1500 Remount Road in Front ...
(Date:2/5/2016)... On Thursday, February 11, 2-1-1 San ... health and disaster services, and the Community Information ... care coordination and service delivery for the community to ... to better connect service providers to the information they ... Diego has handled more than 2.5 million ...
(Date:2/4/2016)... , February 4, 2016 - New FDA action date ... New FDA action date of July 22, ... July 22, 2016   - Lifitegrast ... the past decade indicated for the treatment of signs and symptoms of ... has the potential to be the only product approved in the U.S. in the ...
Breaking Biology Technology:
(Date:1/27/2016)... Jan. 27, 2016  Rite Track, Inc. a leading ... West Chester, Ohio announced today the ... staff, based in Austin, Texas , ... to provide modifications, installations and technical support offerings for ... of PLUS, commented, "PLUS has provided world class service ...
(Date:1/25/2016)... 25, 2016  Glencoe Software, the world-leading supplier of ... industries, will provide the data management solution OMERO Plus ... Photo - ... Phenotypic analysis measures the characteristics and ... comparisons between states such as health and disease, the ...
(Date:1/22/2016)... 22, 2016 ... the "Global Biometrics Market in Retail ... --> http://www.researchandmarkets.com/research/p74whf/global_biometrics ) has ... Biometrics Market in Retail Sector 2016-2020" ... Research and Markets ( http://www.researchandmarkets.com/research/p74whf/global_biometrics ) ...
Breaking Biology News(10 mins):